Table of Contents

2019-2024 Global Transdermal Drug Patches Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Transdermal Drug Patches Consumption 2014-2024
  • 2.1.2 Transdermal Drug Patches Consumption CAGR by Region
• 2.2 Transdermal Drug Patches Segment by Type
  • 2.2.1 Fentanyl Transdermal Patch
  • 2.2.2 Nicotine Transdermal Patch
  • 2.2.3 Buprenorphine Transdermal Patch
  • 2.2.4 Clonidine Transdermal Patch
  • 2.2.5 Oxybutynin Transdermal Patch
  • 2.2.6 Others
• 2.3 Transdermal Drug Patches Consumption by Type
  • 2.3.1 Global Transdermal Drug Patches Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Transdermal Drug Patches Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Transdermal Drug Patches Sale Price by Type (2014-2019)
• 2.4 Transdermal Drug Patches Segment by Application
  • 2.4.1 Used for Hypertension
  • 2.4.2 Used for Contraception
  • 2.4.3 Used for Analgesia
  • 2.4.4 Used for Smoking Cessation
  • 2.4.5 Used for Angina
  • 2.4.6 Used for Hormone Replacement
• 2.5 Transdermal Drug Patches Consumption by Application
  • 2.5.1 Global Transdermal Drug Patches Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Transdermal Drug Patches Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Transdermal Drug Patches Sale Price by Application (2014-2019)

3 Global Transdermal Drug Patches by Players

• 3.1 Global Transdermal Drug Patches Sales Market Share by Players
  • 3.1.1 Global Transdermal Drug Patches Sales by Players (2017-2019)
  • 3.1.2 Global Transdermal Drug Patches Sales Market Share by Players (2017-2019)
• 3.2 Global Transdermal Drug Patches Revenue Market Share by Players
  • 3.2.1 Global Transdermal Drug Patches Revenue by Players (2017-2019)
  • 3.2.2 Global Transdermal Drug Patches Revenue Market Share by Players (2017-2019)
• 3.3 Global Transdermal Drug Patches Sale Price by Players
• 3.4 Global Transdermal Drug Patches Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Transdermal Drug Patches Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Transdermal Drug Patches Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Transdermal Drug Patches by Regions

• 4.1 Transdermal Drug Patches by Regions
  • 4.1.1 Global Transdermal Drug Patches Consumption by Regions
  • 4.1.2 Global Transdermal Drug Patches Value by Regions
• 4.2 Americas Transdermal Drug Patches Consumption Growth
• 4.3 APAC Transdermal Drug Patches Consumption Growth
• 4.4 Europe Transdermal Drug Patches Consumption Growth
• 4.5 Middle East & Africa Transdermal Drug Patches Consumption Growth

5 Americas

• 5.1 Americas Transdermal Drug Patches Consumption by Countries
  • 5.1.1 Americas Transdermal Drug Patches Consumption by Countries (2014-2019)
  • 5.1.2 Americas Transdermal Drug Patches Value by Countries (2014-2019)
• 5.2 Americas Transdermal Drug Patches Consumption by Type
• 5.3 Americas Transdermal Drug Patches Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Transdermal Drug Patches Consumption by Countries
  • 6.1.1 APAC Transdermal Drug Patches Consumption by Countries (2014-2019)
  • 6.1.2 APAC Transdermal Drug Patches Value by Countries (2014-2019)
• 6.2 APAC Transdermal Drug Patches Consumption by Type
• 6.3 APAC Transdermal Drug Patches Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Transdermal Drug Patches by Countries
  • 7.1.1 Europe Transdermal Drug Patches Consumption by Countries (2014-2019)
  • 7.1.2 Europe Transdermal Drug Patches Value by Countries (2014-2019)
• 7.2 Europe Transdermal Drug Patches Consumption by Type
• 7.3 Europe Transdermal Drug Patches Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Transdermal Drug Patches by Countries
  • 8.1.1 Middle East & Africa Transdermal Drug Patches Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Transdermal Drug Patches Value by Countries (2014-2019)
• 8.2 Middle East & Africa Transdermal Drug Patches Consumption by Type
• 8.3 Middle East & Africa Transdermal Drug Patches Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Transdermal Drug Patches Distributors
• 10.3 Transdermal Drug Patches Customer

11 Global Transdermal Drug Patches Market Forecast

• 11.1 Global Transdermal Drug Patches Consumption Forecast (2019-2024)
• 11.2 Global Transdermal Drug Patches Forecast by Regions
  • 11.2.1 Global Transdermal Drug Patches Forecast by Regions (2019-2024)
  • 11.2.2 Global Transdermal Drug Patches Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Transdermal Drug Patches Forecast by Type
• 11.8 Global Transdermal Drug Patches Forecast by Application

12 Key Players Analysis

• 12.1 Noven
  • 12.1.1 Company Details
  • 12.1.2 Transdermal Drug Patches Product Offered
  • 12.1.3 Noven Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 Noven News
• 12.2 Mylan
  • 12.2.1 Company Details
  • 12.2.2 Transdermal Drug Patches Product Offered
  • 12.2.3 Mylan Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 Mylan News
• 12.3 Novartis
  • 12.3.1 Company Details
  • 12.3.2 Transdermal Drug Patches Product Offered
  • 12.3.3 Novartis Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 Novartis News
• 12.4 Johnson & Johnson
  • 12.4.1 Company Details
  • 12.4.2 Transdermal Drug Patches Product Offered
  • 12.4.3 Johnson & Johnson Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 Johnson & Johnson News
• 12.5 Agile Therapeutics
  • 12.5.1 Company Details
  • 12.5.2 Transdermal Drug Patches Product Offered
  • 12.5.3 Agile Therapeutics Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 Agile Therapeutics News
• 12.6 Teikoku Pharma USA
  • 12.6.1 Company Details
  • 12.6.2 Transdermal Drug Patches Product Offered
  • 12.6.3 Teikoku Pharma USA Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.6.4 Main Business Overview
  • 12.6.5 Teikoku Pharma USA News
• 12.7 Immune Pharmaceuticals
  • 12.7.1 Company Details
  • 12.7.2 Transdermal Drug Patches Product Offered
  • 12.7.3 Immune Pharmaceuticals Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.7.4 Main Business Overview
  • 12.7.5 Immune Pharmaceuticals News
• 12.8 Hercon Pharmaceuticals
  • 12.8.1 Company Details
  • 12.8.2 Transdermal Drug Patches Product Offered
  • 12.8.3 Hercon Pharmaceuticals Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.8.4 Main Business Overview
  • 12.8.5 Hercon Pharmaceuticals News
• 12.9 Pocono
  • 12.9.1 Company Details
  • 12.9.2 Transdermal Drug Patches Product Offered
  • 12.9.3 Pocono Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.9.4 Main Business Overview
  • 12.9.5 Pocono News
• 12.10 DURECT Corporation
  • 12.10.1 Company Details
  • 12.10.2 Transdermal Drug Patches Product Offered
  • 12.10.3 DURECT Corporation Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.10.4 Main Business Overview
  • 12.10.5 DURECT Corporation News
• 12.11 Xel Pharmaceuticals

13 Research Findings and Conclusion

A transdermal drug patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Transdermal patches are presently being marketed which can be worn anywhere from as little as eight hours to as long as seven days, depending on their therapeutic indication.
Transdermal drug patches production has relatively high technology barrier and is technology intensive industry. Currently, there are many producing companies in the USA transdermal drug patches industry. The main market players are Noven, Mylan, Novartis and Johnson & Johnson. The production of transdermal drug patches will increase to 477482 K Units in 2016 from 340530 K Units in 2011 with average growth rate of 7.00%. USA transdermal drug patches capacity utilization rate remained at around 76.86% in 2015.
Transdermal drug patches mainly has some types, which include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch and oxybutynin transdermal patch. With medical effect of transdermal drug patches, the downstream application industries will need more transdermal drug patches products.
The major raw materials for transdermal drug patches are scopolamine, clonidine, nitroglycerin, isosorbide dinitrate, estradiol, norethindrone acetate and fentanyl, etc. Fluctuations in the price of the upstream product will impact on the production cost of transdermal drug patches, and then impact the price of transdermal drug patches. The production cost of transdermal drug patches is also an important factor which could impact the price of transdermal drug patches. The transdermal drug patches manufacturers are trying to produce many more types of transdermal drug patches for other different diseases.

According to this study, over the next five years the Transdermal Drug Patches market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Transdermal Drug Patches business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Transdermal Drug Patches market by product type, application, key manufacturers and key regions and countries.

This study considers the Transdermal Drug Patches value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Fentanyl Transdermal Patch
Nicotine Transdermal Patch
Buprenorphine Transdermal Patch
Clonidine Transdermal Patch
Oxybutynin Transdermal Patch
Others
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Used for Hypertension
Used for Contraception
Used for Analgesia
Used for Smoking Cessation
Used for Angina
Used for Hormone Replacement

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Noven
Mylan
Novartis
Johnson & Johnson
Agile Therapeutics
Teikoku Pharma USA
Immune Pharmaceuticals
Hercon Pharmaceuticals
Pocono
DURECT Corporation
Xel Pharmaceuticals

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Transdermal Drug Patches consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Transdermal Drug Patches market by identifying its various subsegments.
Focuses on the key global Transdermal Drug Patches manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Transdermal Drug Patches with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Transdermal Drug Patches submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.